Article ISI
FRONTIERS IN MEDICINE  (2020)

First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia

Valenzuela, Omar; Roessler, Patricia; Roizen, Gigia; Iruretagoyena, Mirentxu; Agar, Vivianne; Fierro, Margarita; Montes, Jose

Abstract

Introduction/objectives: An interleukin-6 inhibition strategy could be effective in selected COVID-19 patients. The objective is to present our experience of tocilizumab use in patients with severe COVID-19.

Más información

Título según WOS: First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia
Título de la Revista: FRONTIERS IN MEDICINE
Volumen: 7
Editorial: LAUSANNE
Fecha de publicación: 2020
DOI:

10.3389/FMED.2020.596916
Notas: ISI